Ménière’s disease

Ménière's disease

Ménière’s is characterized by recurrent episodes of vertigo, fluctuating hearing loss and tinnitus. It affects between 0. 3 and 1. 9 per 1,000 people. Other conditions that may produce similar symptoms include vestibular migraine and transient ischemic attack. Attacks are often treated with medications to help with the nausea and anxiety. Measures to prevent attacks are overall poorly supported by the evidence.

About Ménière’s disease in brief

Summary Ménière's diseaseMénière’s is characterized by recurrent episodes of vertigo, fluctuating hearing loss and tinnitus. It affects between 0. 3 and 1. 9 per 1,000 people. Symptoms are believed to occur as the result of increased fluid build up in the labyrinth of the inner ear. Other conditions that may produce similar symptoms include vestibular migraine and transient ischemic attack. A cure does not exist. Attacks are often treated with medications to help with the nausea and anxiety. Measures to prevent attacks are overall poorly supported by the evidence. A low-salt diet, diuretics, and corticosteroids may be tried. Physical therapy may help with balance and counselling mayhelp with anxiety. Injections into the ear or surgery may also be tried if other measures are not effective, but are associated with risks. The use of tympanostomy tubes, while popular, is not supported. The initial triggers of Ménière’s disease are not fully understood, with a variety of potential inflammatory causes that lead to endolymphatic hydrops (EH) EH is strongly associated with developing MD, but not everyone with EH develops MD.

The mechanism of MD is not fully explained by EH, but fully developed EH may mechanically and chemically interfere with the sensory cells for balance and hearing, which can lead to temporary dysfunction and even to death of the sensory Cells. People who have had a transient stroke or stroke can present with similar symptoms to MD, and in people at risk of a stroke or risk of TIA, magnetic resonance imaging should be conducted to exclude magnetic resonance resonance imaging or TIA or a stroke. The corresponding subtypes of MD are vestibial MD and cochlear MD, showing symptoms of hearing loss. In MAVV, hearing loss is usually in both ears, and this is rare in this condition. In MD, this is usually in both ears and it does not progress in many ways, but this is not rare in MAV-VVV. It is generally generally generally unexplained in MAV, but there are cases where it does progress in this way as it does in MD, generally in people who have vestibulopathy, schwannoma, or a recurrent unilateral vestibule tumor.